BIOCQ — Biocept Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$4.46m
- $25.86m
Annual cashflow statement for Biocept, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.6 | -25.1 | -17.8 | -2.82 | -32.1 |
| Depreciation | |||||
| Non-Cash Items | 0.614 | 2.56 | 3.2 | 5.54 | 3.86 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.801 | -1.4 | -6.27 | -0.552 | 13.3 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -22.4 | -23 | -19.8 | 3.69 | -13.3 |
| Capital Expenditures | -0.145 | -0.735 | -0.867 | -1.57 | -0.807 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.145 | -0.735 | -0.867 | -1.57 | -0.807 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 23.8 | 29.7 | 25.7 | 12.4 | -1.87 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.28 | 5.88 | 5.07 | 14.5 | -16 |